PHP
THC icon

Parkman Healthcare Partners’s Tenet Healthcare THC Stock Holding History

Parkman Healthcare Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Buy
97,280
+47,157
+94% +$8.67M 1.86% 21
2026
Q1 		$9.46M Sell
50,123
-10,391
-17% -$2.19M 0.98% 36
2025
Q4 		$12M Sell
60,514
-13,816
-19% -$2.79M 1.14% 33
2025
Q3 		$15.1M Sell
74,330
-94,554
-56% -$16.8M 1.57% 19
2025
Q2 		$29.7M Sell
168,884
-44,534
-21% -$6.7M 3.42% 5
2025
Q1 		$28.7M Buy
213,418
+106,431
+99% +$14M 3.4% 5
2024
Q4 		$13.5M Buy
106,987
+13,234
+14% +$1.97M 1.8% 18
2024
Q3 		$15.6M Sell
93,753
-55,174
-37% -$8.34M 1.99% 15
2024
Q2 		$19.8M Sell
148,927
-134,926
-48% -$16.2M 2.65% 6
2024
Q1 		$29.8M Sell
283,853
-72,953
-20% -$6.56M 3.66% 1
2023
Q4 		$27M Buy
356,806
+130,665
+58% +$8.28M 3.8% 5
2023
Q3 		$14.9M Sell
226,141
-27,896
-11% -$2.09M 2.73% 7
2023
Q2 		$20.7M Buy
254,037
+68,205
+37% +$4.86M 3.58% 5
2023
Q1 		$11M Buy
185,832
+59,327
+47% +$3.3M 2.4% 8
2022
Q4 		$6.17M Sell
126,505
-32,519
-20% -$1.5M 1.64% 18
2022
Q3 		$8.2M Buy
159,024
+66,834
+72% +$3.97M 2.33% 11
2022
Q2 		$4.85M Sell
92,190
-46,995
-34% -$3.27M 1.78% 19
2022
Q1 		$12M Buy
139,185
+99,185
+248% +$8.15M 3.5% 6
2021
Q4 		$3.27M Buy
+40,000
New +$2.92M 0.72% 40

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Parkman Healthcare Partners's THC Position: Q2 2026 in Review

Parkman Healthcare Partners increased its Tenet Healthcare (THC) stake by 94% in Q2 2026, buying an estimated $8.67M and bringing the position to 97,280 shares worth $18.2M. The position accounts for 1.86% of the portfolio, ranked #21.

Parkman Healthcare Partners first reported a position in THC in Q4 2021 and has held it in 19 quarters since. The position peaked at $29.8M in Q1 2024. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Parkman Healthcare Partners held 97,280 shares of Tenet Healthcare worth $18.2M as of Q2 2026.
  • Parkman Healthcare Partners bought 47,157 Tenet Healthcare shares in Q2 2026, an estimated $8.67M.
  • Tenet Healthcare made up 1.86% of Parkman Healthcare Partners's portfolio in Q2 2026, its #21 holding.
  • Parkman Healthcare Partners first reported a position in Tenet Healthcare in Q4 2021 and has held it in 19 quarters since.
  • Parkman Healthcare Partners's Tenet Healthcare position peaked at $29.8M in Q1 2024.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.